For me it has to be Pfizer - already big in the RA and smoking cessation game and would not want another competing class of compounds to diminish the sales of their assets.
Ann: Invion - successful completion of P2 study of INV102, page-38
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(20.0%) |
Mkt cap ! $26.41M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $500 | 125K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 12434395 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 5290539 | 23 |
View Market Depth
| Last trade - 10.04am 04/07/2024 (20 minute delay) ? |
| IVX (ASX) Chart |